Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
November 3, 2016
S2 from equine infectious anemia virus is an infectivity factor which counteracts the retroviral inhibitors SERINC5 and SERINC3
Ajit Chande, Emilia Cristiana Cuccurullo, Annachiara Rosa, et al.
Plos Pathogens
|
July 17, 2015
Lv4 Is a Capsid-Specific Antiviral Activity in Human Blood Cells That Restricts Viruses of the SIVMAC/SIVSM/HIV-2 Lineage Prior to Integration
Massimo Pizzato, Sean Matthew McCauley, Martha R Neagu, et al.
Retrovirology
|
April 12, 2013
Gelsolin activity controls efficient early HIV-1 infection
Laura García-Expósito, Serena Ziglio, Jonathan Barroso-González, et al.
Nature
|
September 30, 2015
HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation
Annachiara Rosa, Ajit Chande, Serena Ziglio, et al.
Retrovirology
|
June 25, 2015
The HDAC6/APOBEC3G complex regulates HIV-1 infectiveness by inducing Vif autophagic degradation
María-Soledad Valera, Laura de Armas-Rillo, Jonathan Barroso-González, et al.
Scientific Reports
|
May 23, 2018
Corrigendum: HIV-1 Env associates with HLA-C free-chains at the cell membrane modulating viral infectivity
Michela Serena, Francesca Parolini, Priscilla Biswas, et al.
Scientific Reports
|
January 5, 2017
HIV-1 Env associates with HLA-C free-chains at the cell membrane modulating viral infectivity
Michela Serena, Francesca Parolini, Priscilla Biswas, et al.
Journal of Translational Medicine
|
July 13, 2012
Rational design of HIV vaccines and microbicides: report of the EUROPRISE annual conference 2011
Nicolas Ruffin, Marie Borggren, Zelda Euler, et al.
Journal of Translational Medicine
|
April 14, 2011
Rational design of HIV vaccines and microbicides: report of the EUROPRISE network annual conference 2010
Sarah Brinckmann, Kelly da Costa, Marit J van Gils, et al.
Human Molecular Genetics
|
February 19, 2015
Galanin pathogenic mutations in temporal lobe epilepsy
Michel Guipponi, Amina Chentouf, Kristin E B Webling, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Proceedings of the National Academy of Sciences of the United States of America
|
November 3, 2016
S2 from equine infectious anemia virus is an infectivity factor which counteracts the retroviral inhibitors SERINC5 and SERINC3
Ajit Chande, Emilia Cristiana Cuccurullo, Annachiara Rosa, et al.
Plos Pathogens
|
July 17, 2015
Lv4 Is a Capsid-Specific Antiviral Activity in Human Blood Cells That Restricts Viruses of the SIVMAC/SIVSM/HIV-2 Lineage Prior to Integration
Massimo Pizzato, Sean Matthew McCauley, Martha R Neagu, et al.
Retrovirology
|
April 12, 2013
Gelsolin activity controls efficient early HIV-1 infection
Laura García-Expósito, Serena Ziglio, Jonathan Barroso-González, et al.
Nature
|
September 30, 2015
HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation
Annachiara Rosa, Ajit Chande, Serena Ziglio, et al.
Retrovirology
|
June 25, 2015
The HDAC6/APOBEC3G complex regulates HIV-1 infectiveness by inducing Vif autophagic degradation
María-Soledad Valera, Laura de Armas-Rillo, Jonathan Barroso-González, et al.
Scientific Reports
|
May 23, 2018
Corrigendum: HIV-1 Env associates with HLA-C free-chains at the cell membrane modulating viral infectivity
Michela Serena, Francesca Parolini, Priscilla Biswas, et al.
Scientific Reports
|
January 5, 2017
HIV-1 Env associates with HLA-C free-chains at the cell membrane modulating viral infectivity
Michela Serena, Francesca Parolini, Priscilla Biswas, et al.
Journal of Translational Medicine
|
July 13, 2012
Rational design of HIV vaccines and microbicides: report of the EUROPRISE annual conference 2011
Nicolas Ruffin, Marie Borggren, Zelda Euler, et al.
Journal of Translational Medicine
|
April 14, 2011
Rational design of HIV vaccines and microbicides: report of the EUROPRISE network annual conference 2010
Sarah Brinckmann, Kelly da Costa, Marit J van Gils, et al.
Human Molecular Genetics
|
February 19, 2015
Galanin pathogenic mutations in temporal lobe epilepsy
Michel Guipponi, Amina Chentouf, Kristin E B Webling, et al.
Page
of 1